Dr. Sotomayor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 Usf Magnolia Dr
# Mdc
Tampa, FL 33612Phone+1 813-745-3980Fax+1 813-745-7264
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1995 - 1998
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1992 - 1995
National University of Federico Villarreal Faculty of MedicineClass of 1988
Certifications & Licensure
FL State Medical License 2000 - 2026
DC State Medical License 2015 - 2022
MD State Medical License 1995 - 2021
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
Clinical Trials
- Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL Start of enrollment: 2012 Mar 30
Publications & Presentations
PubMed
- 1275 citationsImmunosuppressive Strategies that are Mediated by Tumor CellsGabriel A. Rabinovich, Dmitry I. Gabrilovich, Eduardo M. Sotomayor
Annual Review of Immunology. 2007-03-21 - 184 citationsVaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular LymphomaStephen J. Schuster, Sattva S. Neelapu, Barry L. Gause, John E. Janik, Franco M. Muggia
Journal of Clinical Oncology. 2011-07-10 - 361 citationsAll-trans-Retinoic Acid Eliminates Immature Myeloid Cells from Tumor-bearing Mice and Improves the Effect of VaccinationSergei Kusmartsev, Fengdong Cheng, Bin Yu, Yulia Nefedova, Eduardo M. Sotomayor
Cancer Research. 2003-08-01
Abstracts/Posters
- Assessment of Different Biological Variables (Serum Albumin, _-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a...Eduardo Sotomayor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Selective Targeting of Histone Deacetylase 11 Disables Metabolism of Myeloproliferative NeoplasmsEduardo Sotomayor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study ...Eduardo Sotomayor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Tampa General Hospital’s New Bone Marrow Transplant and Cell Therapies Unit Saved a Palm Beach County Patient’s LifeApril 1st, 2023- Tampa General Hospital Cancer Institute Expands Its Radiation Oncology Program with World-Renowned Physicians and a State-of-the-Art Proton Therapy Center, Bringing Greater Access to Best-in-Class Cancer Treatment to PatientsJanuary 13th, 2023
- Tampa General Hospital Cancer Institute Is Expanding and Now Providing Comprehensive Cancer Treatment Services to the Brandon Area and Surrounding CommunitiesNovember 9th, 2022
- Join now to see all
Grant Support
- Targeting Negative Regulatory Pathways For Immunotherapy Of B-Cell LymphomasNational Cancer Institute2010–2012
- Regulation Of Cross-Tolerance To Tumor AntigensNational Cancer Institute2003–2012
- Solid Tumors Induced T-Cell ToleranceNational Cancer Institute2005–2009
- Solid Tumors Induced T Cell ToleranceNational Cancer Institute2001–2004
- Mechanism(S) Involved In Tumor Induced ToleranceNational Cancer Institute1999–2001
- Mechanism(S) Involved In Tumor Induced ToleranceNational Cancer Institute1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
